Social Media Ideas for Fda Approval

<![CDATA[Pharmaceutical Executive Daily: FDA Grants Traditional Approval to Novartis's Fabhalta]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Orezeyful]]>

<![CDATA[FDA Approves Fabhalta to Slow Kidney Function Decline in Primary IgAN in Adults ]]>

<![CDATA[FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia ]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Zanvastro]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Simtriyo]]>

<![CDATA[FDA Pannel Votes to Loosen Restrictions for Four Peptides ]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Lipfendra]]>

<![CDATA[FDA Approves Leqembi Iqlik Subcutaneous Injection for Early Alzheimer’s Disease]]>

<![CDATA[FDA Approves Imaavy for Warm Autoimmune Hemolytic Anemia in Patients Aged 12 and Older]]>

<![CDATA[FDA Approves Zanvastro for Alexander Disease in Pediatrics & Adults ]]>

<![CDATA[FDA Grants Accelerated Approval to Tudriqev in Combination with Nivoumab for Advanced Melanoma]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Imaavy for wAIHA]]>

<![CDATA[FDA Approves Pasatru For Adults With Fibrodysplasia Ossificans Progressiva ]]>

<![CDATA[FDA Grants Accelerated Approval to Zenbexus Plus Daratumumab and Hyaluronidase-fihj and Dexamethasone for Mu...

<![CDATA[FDA Approves Orezeyful for Narcolepsy Type 1 in Adults ]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Pasatru]]>

<![CDATA[FDA Approves Lisraya for Adults with Dermatomyositis, Bixlenvo for Virologically Suppressed Adults with HIV,...

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Subcutaneous Formulation of Leqembi Iqlik]]>

Replimune rebounds to win FDA approval of melanoma drug

The accelerated clearance follows two earlier rejections and the support of an advisory panel that disputed the arguments of FDA scientists.

FDA Eases Approval Path for Certain Cancer Companion Diagnostic Tests

The U.S. Food and Drug Administration has issued a final order moving certain laboratory tests used to help guide treatment with approved cancer drugs from...

FDA Panel Backs Two Peptides For Compounding, Rejects One

MONDAY, July 27, 2026 — A federal advisory panel has recommended allowing compounding pharmacies to make two more unproven peptides while voting to reject a third.The U.S. Food an...

<![CDATA[FDA Approves Otsuka’s First-In-Class Simtriyo for Adults & Pediatric Patients ]]>

<![CDATA[FDA Approves Daraxonrasib as First-in-Class Targeted Therapy for Metastatic Pancreatic Cancer]]>